‘You Never Know When Things Could Change in an Instant’ Says Pediatric Cancer Survivor

Article

In an interview with CURE®, Emily Whitehead details her journey as a pediatric cancer survivor and how you won’t be able to predict it.

Emily Whitehead was just five years old when she was diagnosed with standard-risk pre-b acute lymphoblastic leukemia (ALL) in 2010. Though her parents, Tom and Kari, were told that she had a good chance of recovery, Emily underwent 16 months of chemotherapy. Then, just two weeks before a scheduled bone marrow transplant, Emily relapsed for a second time.

The Whiteheads thought they were out of options, until a phase 1 trial examining the use of CAR-T cell therapy opened up at Children’s Hospital of Philadelphia (CHOP) in April 2012, making Emily the first child to receive CAR-T cell therapy. This treatment turned out to be what the Whiteheads now call a miracle, and here, Emily, who has been in remission since May 2012, offers her take on what it was like to go through treatment and offers some advice to other patients who may be in a similar situation.

Transcription:

CURE: What was it like going through cancer treatment as a child?

Emily: It's definitely a really difficult thing to go through, and you really need the support of other people, whether that be friends or family, or even a pet like my dog, Lucy. But I'm just so glad that more people have access to the treatment now, to less toxic treatments. And really all that you can do is just never stop and always keep fighting and just try to keep hoping you'll get through it.

What advice do you have for other patients with pediatric cancer?

I always tell them to never give up, to always keep fighting and to always believe in yourself and just to try and smile every day because you never know when things could change in an instant.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE